Feifei Han

机构：Capital Medical University, Beijing Chao-Yang Hospital, Capital Medical University · ORCID：0000-0001-5074-8875

发表论文 7 篇 · 总被引 208 次 · h-index 6

代表论文

• Oral administration of yeast β-glucan ameliorates inflammation and intestinal barrier in dextran sodium sulfate-induced acute colitis (2017 · Journal of Functional Foods · 被引 73)
• Arginase: Biological and Therapeutic Implications in Diabetes Mellitus and Its Complications (2022 · Oxidative Medicine and Cellular Longevity · 被引 45)
• LFP-20, a porcine lactoferrin peptide, ameliorates LPS-induced inflammation via the MyD88/NF-κB and MyD88/MAPK signaling pathways (2015 · Developmental & Comparative Immunology · 被引 44)
• Targeted Metabolomics for Plasma Amino Acids and Carnitines in Patients with Metabolic Syndrome Using HPLC-MS/MS (2020 · Disease Markers · 被引 19)
• ETNPPL modulates hyperinsulinemia‐induced insulin resistance through the SIK1/ROS‐mediated inactivation of the PI3K/AKT signaling pathway in hepatocytes (2023 · Journal of Cellular Physiology · 被引 16)
• C2CD4A/B variants in the predisposition of lung cancer in the Chinese Han population (2022 · Functional & Integrative Genomics · 被引 7)